ARCHIVES

FDA Designates Zometa For Priority Review.

This article is from The Cancer Letter archive.

Vol. 27 No. 44 | November 30, 2001

Download PDF Visit The Full Archive

Related Articles

Alan Davis to Retire From ACS; Five Execs Keep Top Positions

September 10, 1993

Platinum-Free Break Enhances Therapy After First Relapse In Ovarian Cancer

March 28, 2003

Also AIDS Malignancy Consortium grants to be consolidated on recompetition to one central group chairman’s office.

November 19, 2004

Is Everyone in Academic Medicine Unhappy? Or is it Just MD Anderson?

December 12, 2014

AACR Supports 5 Percent Increase in NCI Budget.

April 7, 2006

DCCP To Have Board Of Scientific Counselors

September 1, 1978